These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 24664520)

  • 1. Gut microbiota modulation: probiotics, antibiotics or fecal microbiota transplantation?
    Cammarota G; Ianiro G; Bibbò S; Gasbarrini A
    Intern Emerg Med; 2014 Jun; 9(4):365-73. PubMed ID: 24664520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic modulation of gut microbiota: current clinical applications and future perspectives.
    Ianiro G; Bibbò S; Gasbarrini A; Cammarota G
    Curr Drug Targets; 2014; 15(8):762-70. PubMed ID: 24909808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.
    Suk KT; Kim DJ
    Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic methods of gut microbiota modification in colorectal cancer management - fecal microbiota transplantation, prebiotics, probiotics, and synbiotics.
    Kaźmierczak-Siedlecka K; Daca A; Fic M; van de Wetering T; Folwarski M; Makarewicz W
    Gut Microbes; 2020 Nov; 11(6):1518-1530. PubMed ID: 32453670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal microbiota transplantation: a new old kid on the block for the management of gut microbiota-related disease.
    Cammarota G; Ianiro G; Bibbò S; Gasbarrini A
    J Clin Gastroenterol; 2014; 48 Suppl 1():S80-4. PubMed ID: 25291136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota and allogeneic transplantation.
    Wang W; Xu S; Ren Z; Jiang J; Zheng S
    J Transl Med; 2015 Aug; 13():275. PubMed ID: 26298517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiota Modulation for Therapeutic Management of Various Diseases: A New Perspective Using Stem Cell Therapy.
    Ahmed LA; Al-Massri KF
    Curr Mol Pharmacol; 2023; 16(1):43-59. PubMed ID: 35196976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
    Vemuri RC; Gundamaraju R; Shinde T; Eri R
    Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enteric microbiota leads to new therapeutic strategies for ulcerative colitis.
    Chen WX; Ren LH; Shi RH
    World J Gastroenterol; 2014 Nov; 20(42):15657-63. PubMed ID: 25400449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.
    Distrutti E; Monaldi L; Ricci P; Fiorucci S
    World J Gastroenterol; 2016 Feb; 22(7):2219-41. PubMed ID: 26900286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal microbiota transfer for bowel disorders: efficacy or hype?
    Schmulson M; Bashashati M
    Curr Opin Pharmacol; 2018 Dec; 43():72-80. PubMed ID: 30218939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of the intestinal microbiome: fecal microbiota transplant and probiotics for Clostridium difficile and beyond.
    Vindigni SM; Broussard EK; Surawicz CM
    Expert Rev Gastroenterol Hepatol; 2013 Sep; 7(7):615-28. PubMed ID: 24070153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory Bowel Diseases: The Role of Gut Microbiota.
    De Musis C; Granata L; Dallio M; Miranda A; Gravina AG; Romano M
    Curr Pharm Des; 2020; 26(25):2951-2961. PubMed ID: 32310042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiota modulation-based therapy for luminal GI disorders: current applications of probiotics and fecal microbiota transplantation.
    Elangovan A; Allegretti JR; Fischer M
    Expert Opin Biol Ther; 2019 Dec; 19(12):1343-1355. PubMed ID: 31570017
    [No Abstract]   [Full Text] [Related]  

  • 15. Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease.
    Wang ZK; Yang YS; Chen Y; Yuan J; Sun G; Peng LH
    World J Gastroenterol; 2014 Oct; 20(40):14805-20. PubMed ID: 25356041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome.
    König J; Brummer RJ
    Benef Microbes; 2014 Sep; 5(3):247-61. PubMed ID: 24583610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotics and antibiotics in IBD.
    Sokol H
    Dig Dis; 2014; 32 Suppl 1():10-7. PubMed ID: 25531348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis.
    Haak BW; Prescott HC; Wiersinga WJ
    Front Immunol; 2018; 9():2042. PubMed ID: 30250472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Gut Microbiota in Type 2 Diabetes Mellitus and Its Complications: Novel Insights and Potential Intervention Strategies.
    Woldeamlak B; Yirdaw K; Biadgo B
    Korean J Gastroenterol; 2019 Dec; 74(6):314-320. PubMed ID: 31870137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.